Dermapharm Holding SE
XHAM:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
C
|
Central Japan Railway Co
SWB:JAP
|
JP |
|
Grupo Aeroportuario del Centro Norte SAB De CV
BMV:OMAB
|
MX |
|
C
|
Central Japan Railway Co
F:JAP
|
JP |
|
B
|
Biogen Inc
XMUN:IDP
|
US |
|
Everbright Securities Co Ltd
F:0EC
|
CN |
|
A
|
Archer-Daniels-Midland Co
XMUN:ADM
|
US |
|
Lemonade Inc
F:LE0
|
US |
|
Next PLC
LSE:NXT
|
UK |
|
B
|
Blackstone Mortgage Trust Inc
F:079A
|
US |
|
Industrias Penoles SAB de CV
OTC:IPOAF
|
MX |
|
Carlisle Companies Inc
NYSE:CSL
|
US |
|
A
|
Archer-Daniels-Midland Co
LSE:0JQQ
|
US |
|
B
|
Booking Holdings Inc
F:PCE1
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
SWB:75C
|
CN |
|
NewPrinces SpA
F:6NF
|
IT |
|
F
|
Farmland Partners Inc
SWB:0FA
|
US |
|
Marchex Inc
NASDAQ:MCHX
|
US |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
Radiant Logistics Inc
F:3GT
|
US |
Bankruptcy Probability
Dermapharm Holding SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dermapharm Holding SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Dermapharm Holding SE
XETRA:DMP
|
1.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
2.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
344.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
268.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dermapharm Holding SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dermapharm Holding SE has total debt of 1B EUR. This includes both short-term (26k EUR) and long-term (1B EUR) debt.
You can find a full breakdown on its Balance Sheet.